Anti-FOLR1/FRA Antibody (Mirvetuximab)
Catalog No.
F1092
Anti-FOLR1/FRA Antibody (Mirvetuximab)
Featured Products
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is a novel folate receptor α (FRα) targeted ADC (Mirvetuximab soravtansine) antibody molecule. Mirvetuximab soravtansine can be used in the research of ovarian cancer and other FRα-positive cancers.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
1453084-36-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
M9346A
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P15328
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human FRa His at 2 ug/mL can bind Anti-FOLR1/FRA Antibody (Mirvetuximab)
FOLR1 / FRA
Please avoid freeze-thaw cycles.